Companies: 10,795·Total market cap: $144.5T
Lucy Scientific Discovery Inc.

Lucy Scientific Discovery Inc.

LSDINASDAQHealthcare
$0.51
$-0.16(-23.29%)
Market Cap$906910
P/E Ratio
52W High$12.8
52W Low$0.44

Lucy Scientific Discovery Inc. (LSDI) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

LSDI · free cash flow · updated Jun 9, 2026

Core FCF metrics

Free cash flow was −$4.6M for FY2023 (fiscal year ending 2023-06-30), down 86.2% year-over-year

FY2023 Free Cash Flow−$4.6M▼ -86.2% YoY
Trailing 12M (TTM)−$5.9Mtrailing 4 quarters sum
FCF Margin< −999%−$4.6M ÷ revenue
3-Year CAGRN/AN/A — contains negative FCF
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
lsdi free cash flow history · lsdi free cash flow chart · lsdi free cash flow growth rate · lsdi free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2023Latest−$4.6M▼ 86.2%
FY2022−$2.5M▼ 65.2%
FY2021−$1.5M▼ 197.4%
FY2020−$499,157
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
lsdi free cash flow 2023 · lsdi free cash flow 2022 · lsdi free cash flow 2021 · lsdi operating cash flow

FCF valuation metrics

Lucy Scientific Discovery Inc. (LSDI) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)
N/A
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
N/A
TTM FCF ÷ Shares Outstanding
Price / FCF
N/A
Share Price ÷ FCF per Share
EV / FCF (TTM)
N/A
Enterprise Value basis
!

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2023 · 2023-06-30
lsdi price to free cash flow · lsdi free cash flow yield · lsdi free cash flow per share · lsdi price to cash flow ratio

Cash flow statement summary

For FY2023, Lucy Scientific Discovery Inc. generated −$4.3M in operating cash flow and spent 0M in capital expenditures, yielding −$4.6M in free cash flow.

Operating Activities
−$4.3M
Cash from core business operations
2023-06-30
Investing Activities
−$0.3M
CapEx, acquisitions & investments
2023-06-30
Financing Activities
+$6.2M
Buybacks, dividends & debt
2023-06-30
FCF FormulaOperating CF (−$4.3M) − |CapEx| (0M) = FCF (−$4.6M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
lsdi cash flow statement · lsdi cash flow statement 2023 · lsdi operating cash flow · lsdi cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Lucy Scientific Discovery Inc.
Lucy Scientific Discovery Inc.YOU
LSDI
−$4.6M-86.2%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Lucy Scientific Discovery Inc. (LSDI) reported free cash flow of −$4.6M for FY2023 (fiscal year ending 2023-06-30), down 86.2% year-over-year.

Lucy Scientific Discovery Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 4 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

LSDI free cash flow · 8 questions

Lucy Scientific Discovery Inc. free cash flow was −$4.6M for FY2023, down 86.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$5.9M.

LSDI free cash flowLSDI FCFLSDI FCF 2023LSDI free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Lucy Scientific Discovery Inc. · Lucy Scientific Discovery Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026